Dr Reddy's Laboratories Long Term Debt 2010-2024 | RDY

Dr Reddy's Laboratories long term debt for the quarter ending June 30, 2024 was $0.075B, a 25% increase year-over-year.

  • Dr Reddy's Laboratories long term debt for 2024 was $0.072B, a 350% increase from 2023.
  • Dr Reddy's Laboratories long term debt for 2023 was $0.016B, a 78.95% decline from 2022.
  • Dr Reddy's Laboratories long term debt for 2022 was $0.076B, a 11.63% decline from 2021.

Dr Reddy's Laboratories Long Term Debt 2010-2024 | RDY

  • Dr Reddy's Laboratories long term debt for 2024 was $0.072B, a 350% increase from 2023.
  • Dr Reddy's Laboratories long term debt for 2023 was $0.016B, a 78.95% decline from 2022.
  • Dr Reddy's Laboratories long term debt for 2022 was $0.076B, a 11.63% decline from 2021.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$20.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Sol-Gel Technologies (SLGL)$20M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M